Biosynex SA reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was EUR 196.6 million compared to EUR 382.5 million a year ago. Net income was EUR 15.6 million compared to EUR 104 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.09 EUR | -0.73% | -19.80% | -51.02% |
2023 | Biosynex: merger with Theradiag completed | CF |
2023 | Biosynex SA Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-51.02% | 46.99M | |
+0.89% | 12.8B | |
-10.29% | 7.61B | |
+1.78% | 5.41B | |
-1.16% | 4.51B | |
+5.74% | 4.49B | |
-50.70% | 3.29B | |
+12.21% | 2.73B | |
-16.13% | 2.02B | |
-11.50% | 1.73B |
- Stock Market
- Equities
- ALBIO Stock
- News Biosynex
- Biosynex SA Reports Earnings Results for the Full Year Ended December 31, 2022